Table-II.

Chi-Square significance values of CMV DNA positivity rates in COVID-19 cases with and without anti-cytokine therapy.

	CMV Positive %		Mortality %
	Chi-Square value	p	Chi-Square value	p
	Group 1 vs-Group 2 (No Anticytokin-TCZ and/or, AKR)	x2=4.535	p: 0.033 a	x2=9.123	p: 0.003 b
Group 1 vs-Group 3 (No Anticytokin - TCZ)	x2=4.082	p: 0.043 a	x2=8.631	p: 0.003 b
Group 1 vs-Group 4 (No Anticytokin - AKR)	x2=6.410	p: 0.011 a	x2=2.761	p: 0.096
Group 1 vs -Group 5 (No Anticytokin-TCZ with and AKR)	x2=3.008	p: 0.083	x2=1.161	p: 0.281
Group 3 vs -Group 4 (TCZ - AKR)	x2=0.590	p: 0.442	x2=0.466	p: 0.495

TCZ:Tocilizumab, AKR: Anakinra ;

^a(p<0.05),

^b(p<0.01); The statistical p-value of <0.05 was considered significant.